In this research we utilize a transgenic murine model of AD, the APP/PS1 mouse [9], which bears a marked forebrain amyloidosis while hindbrain structures, including the cerebellum, are devoid of fibrillar Aβ plaques. The gene discussed is APP; the disease is amyloidosis.